Clinical Insights
Clinical Insights
New targeted treatments are major advances for HER2-positive breast cancer
Clinical Insights
The power and promise of social media in oncology
Dr. Alan Lyss describes a recent presentation on the role of social media in oncology.
Clinical Insights
IMvigor130: A treasure trove of data for urothelial carcinoma
Dr. Alan Lyss reviews updated results with atezolizumab in locally advanced or metastatic urothelial carcinoma.
Clinical Insights
Leveraging the microbiome to enhance cancer treatment
Dr. Alan Lyss reviews research suggesting that an antibiotic can improve the efficacy of radiotherapy.
Clinical Insights
Steroid-refractory pneumonitis from ICIs: Experience at major centers
Clinical Insights
mCODE: Improving data sharing to enhance cancer care
Clinical Insights
Genetic testing for breast and ovarian cancer: What has changed and what still needs to change?
Dr. Alan Lyss reviews a study that revealed trends in genetic testing over time.
Clinical Insights
Enfortumab vedotin offers hope to poor-prognosis patients with advanced urothelial cancer
Clinical Insights
How has the pandemic affected rural and urban cancer patients?
Clinical Insights
X-ray vision: Using AI to maximize the value of radiographic images
Clinical Insights
ctDNA outperforms CEA in colorectal cancer